BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9759844)

  • 1. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
    Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
    Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential human T cell-dependent B cell differentiation induced by staphylococcal superantigens (SAg). Regulatory role for SAg-dependent B cell cytolysis.
    Stohl W; Elliott JE
    J Immunol; 1995 Aug; 155(4):1838-50. PubMed ID: 7636237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
    Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The conventional CD4+ T cell response to staphylococcal enterotoxin B is modified by its superantigenic activity.
    Wen R; Surman S; Blackman MA; Woodland DL
    Cell Immunol; 1997 Mar; 176(2):166-72. PubMed ID: 9073390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK; Hwang LA; Hui KM
    Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
    Stohl W; Xu D; Starling GC; Casali P; Kiener PA
    Cell Immunol; 2000 Jul; 203(1):1-11. PubMed ID: 10915556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
    Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
    Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95.
    McLeod JD; Walker LS; Patel YI; Boulougouris G; Sansom DM
    J Immunol; 1998 Mar; 160(5):2072-9. PubMed ID: 9498743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of mouse Fas antigen on immature and mature T cells.
    Nishimura Y; Ishii A; Kobayashi Y; Yamasaki Y; Yonehara S
    J Immunol; 1995 May; 154(9):4395-403. PubMed ID: 7536770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.